Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study.

Yoshiaki MinakataTakashi MotegiJun UekiYasuhiro GonShuhei NakamuraTatsuhiko AnzaiKazuto HirataMasakazu Ichinose

Published in: International journal of chronic obstructive pulmonary disease (2019)

Tiotropium/olodaterol combination therapy significantly reduced sedentary time and improved physical activity compared with tiotropium monotherapy. This trial was registered in ClinicalTrials.gov (NCT02629965).

Keyphrases

combination therapy
physical activity
chronic obstructive pulmonary disease
body mass index
study protocol
clinical trial
phase iii
randomized controlled trial
cystic fibrosis
depressive symptoms